Price Sensitivity of Demand for Prescription Drugs: Exploiting a Regression Kink Design

Journal of Applied Econometrics

Volumn 31, Issue 2, 2016, Pages 320-337

  Simonsen, Marianne ^a   Skipper, Lars ^a   Skipper, Niels ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84959486730     PISSN: 08837252     EISSN: 10991255     Source Type: Journal    
DOI: 10.1002/jae.2436     Document Type: Article

References (21)

1. Altonji JG, Matzkin RL. 2005. Cross section and panel data estimators for nonseparable models with endogenous regressors. Econometrica 73: 1053-1102.
2. Aron-Dine A, Einav L, Finkelstein A, Cullen M. 2012. Moral hazard in health insurance: how important is forward looking behavior? NBER working paper 17802.
3. Aron-Dine A, Einav L, Finkelstein A. 2013. The RAND health insurance experiment, three decades later. Journal of Economic Perspectives 27: 197-222.
4. Card D, Lee DS, Pei Z, Weber A. 2012. Nonlinear policy rules and the identification and estimation of causal effects in a generalized regression kink design. NBER working paper 18564.
5. Chandra AJ, Gruber J, McKnight, R. 2010. Patient cost-sharing and hospitalization offsets in the elderly. American Economic Review 100: 193-213.
6. Chetty R, Friedman JN, Olsen T, Pistaferri L. 2011. Adjustment costs, firm responses, and micro vs. macro labor supply elasticities: evidence from Danish tax records. Quarterly Journal of Economics 126: 749-804.
7. Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi, G. 2011. Can we use pharmacy data to estimate the prevalence of chronic conditions? A comparison of multiple data sources. BMC Public Health 11: 688.
8. Contoyannis PJ, Hurley J, Grootendorst P, Jeon S, Tablyn R. 2005. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec. Canada, Health Economics 14: 909-923.
9. Florens, JP, Heckman JJ, Meghir C, Vytlacil EJ. 2008. Identification of treatment effects using control functions in models with continuous, endogenous treatment and heterogeneous effects. Econometrica 76: 1191-1206.
10. Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch M. 2004. Pharmacy benefits and the use of drugs by the chronically ill. Journal of the American Medical Association 291: 2344-2350.
11. Keeler EB, Newhouse JP, Phelps CE. 1977. Deductibles and the demand for medical care services: the theory of a consumer facing a variable price schedule under uncertainty. Econometrica 45: 641-655.
12. Landsman PB, Yu W, Liu XF, Teutsch SM, Baerger ML. 2005. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. American Journal of Managed Care 11: 621-628.
13. Manning WG, Newhouse JP, Duan N, Keeler EB, Leibowitz A, Marquis MS. 1987. Health insurance and the demand for medical care: evidence from a randomized experiment. American Economic Review 77: 251-277.
14. McCrary J. 2008. Manipulation of the running variable in the regression discontinuity design: a density test. Journal of Econometrics 142: 698-714.
15. Moffitt R. 1990. The econometrics of kinked budget constraints. Journal of Economic Perspectives 4: 119-139.
16. Newhouse J. 1993. Free for All: Lessons from the RAND Health Insurance Experiment. Harvard University Press: Cambridge, MA.
17. OECD. 2009. Health at a Glance 2009: OECD Indicators. Available: http://www.oecd.org/health/health-systems/44117530.pdf [23 December 2014].
18. Philipson TJ, Becker G, Goldman D, Murphy K. 2010. Terminal care and the value of life near its end. NBER working paper 15649.
19. Saez E. 2010. Do tax filers bunch at kink points? American Economic Journal: Economic Policy 2: 180-212.
20. Simeonova E. 2013. Doctors, patients, and the racial mortality gap. Journal of Health Economics 32: 895-908.
21. Skipper N. 2012. On reimbursement reforms and stockpiling of prescription drugs: the case of insulin. Health Policy 106: 233-240.